Health sciences digest: Drug pricing uproar, antioxidant dangers

By Leila Gray

May 6, 2014

The latest news from the UW Health Sciences and UW Medicine:   What price for a cure? The economics of drug pricing The uproar against the $1,000-a-pill hepatitis C drug Sovaldi, generic name sofosbuvir, may signal a turning point in drug pricing in the United States.  Purchasers appear to be pushing back and saying, “No.”…

Next Page »